PubMed:21145111 JSONTXT

{"project":"bionlp-st-pc-2013-training","denotations":[{"id":"T1","span":{"begin":0,"end":6},"obj":"Complex"},{"id":"T2","span":{"begin":68,"end":73},"obj":"Complex"},{"id":"T3","span":{"begin":74,"end":77},"obj":"Gene_or_gene_product"},{"id":"T4","span":{"begin":118,"end":123},"obj":"Complex"},{"id":"T5","span":{"begin":131,"end":134},"obj":"Gene_or_gene_product"},{"id":"T6","span":{"begin":135,"end":139},"obj":"Complex"},{"id":"T7","span":{"begin":150,"end":169},"obj":"Complex"},{"id":"T8","span":{"begin":232,"end":235},"obj":"Gene_or_gene_product"},{"id":"T9","span":{"begin":396,"end":401},"obj":"Complex"},{"id":"T10","span":{"begin":491,"end":496},"obj":"Complex"},{"id":"T11","span":{"begin":497,"end":500},"obj":"Gene_or_gene_product"},{"id":"T12","span":{"begin":519,"end":524},"obj":"Complex"},{"id":"T13","span":{"begin":566,"end":580},"obj":"Complex"},{"id":"T14","span":{"begin":582,"end":588},"obj":"Complex"},{"id":"T15","span":{"begin":622,"end":627},"obj":"Complex"},{"id":"T16","span":{"begin":673,"end":678},"obj":"Complex"},{"id":"T17","span":{"begin":679,"end":682},"obj":"Gene_or_gene_product"},{"id":"T18","span":{"begin":744,"end":749},"obj":"Complex"},{"id":"T19","span":{"begin":753,"end":759},"obj":"Complex"},{"id":"T20","span":{"begin":831,"end":836},"obj":"Complex"},{"id":"T21","span":{"begin":837,"end":840},"obj":"Gene_or_gene_product"},{"id":"T22","span":{"begin":842,"end":847},"obj":"Complex"},{"id":"T23","span":{"begin":892,"end":895},"obj":"Gene_or_gene_product"},{"id":"T24","span":{"begin":897,"end":900},"obj":"Gene_or_gene_product"},{"id":"T25","span":{"begin":901,"end":933},"obj":"Gene_or_gene_product"},{"id":"T26","span":{"begin":935,"end":939},"obj":"Gene_or_gene_product"},{"id":"T27","span":{"begin":942,"end":989},"obj":"Gene_or_gene_product"},{"id":"T28","span":{"begin":991,"end":1014},"obj":"Gene_or_gene_product"},{"id":"T29","span":{"begin":1016,"end":1019},"obj":"Gene_or_gene_product"},{"id":"T30","span":{"begin":1022,"end":1043},"obj":"Complex"},{"id":"T31","span":{"begin":1045,"end":1050},"obj":"Complex"},{"id":"T32","span":{"begin":1057,"end":1076},"obj":"Complex"},{"id":"T33","span":{"begin":1078,"end":1082},"obj":"Complex"},{"id":"T34","span":{"begin":1109,"end":1112},"obj":"Gene_or_gene_product"},{"id":"T35","span":{"begin":1114,"end":1122},"obj":"Gene_or_gene_product"},{"id":"T36","span":{"begin":1124,"end":1131},"obj":"Gene_or_gene_product"},{"id":"T37","span":{"begin":1136,"end":1141},"obj":"Complex"},{"id":"T38","span":{"begin":1185,"end":1188},"obj":"Gene_or_gene_product"},{"id":"T39","span":{"begin":1193,"end":1197},"obj":"Complex"},{"id":"T40","span":{"begin":1222,"end":1227},"obj":"Complex"},{"id":"T41","span":{"begin":1228,"end":1231},"obj":"Gene_or_gene_product"},{"id":"T42","span":{"begin":1248,"end":1253},"obj":"Complex"},{"id":"T43","span":{"begin":1283,"end":1288},"obj":"Complex"},{"id":"T44","span":{"begin":1299,"end":1304},"obj":"Complex"},{"id":"T45","span":{"begin":1331,"end":1334},"obj":"Gene_or_gene_product"},{"id":"T46","span":{"begin":1336,"end":1344},"obj":"Gene_or_gene_product"},{"id":"T47","span":{"begin":1349,"end":1356},"obj":"Gene_or_gene_product"},{"id":"T48","span":{"begin":1375,"end":1379},"obj":"Complex"},{"id":"T49","span":{"begin":1419,"end":1422},"obj":"Gene_or_gene_product"},{"id":"T50","span":{"begin":1515,"end":1520},"obj":"Complex"},{"id":"T51","span":{"begin":1562,"end":1567},"obj":"Complex"},{"id":"T52","span":{"begin":1568,"end":1571},"obj":"Gene_or_gene_product"},{"id":"T53","span":{"begin":1610,"end":1613},"obj":"Gene_or_gene_product"},{"id":"T54","span":{"begin":1616,"end":1624},"obj":"Gene_or_gene_product"},{"id":"T55","span":{"begin":1631,"end":1638},"obj":"Gene_or_gene_product"},{"id":"T56","span":{"begin":1649,"end":1654},"obj":"Complex"},{"id":"T57","span":{"begin":1677,"end":1680},"obj":"Gene_or_gene_product"},{"id":"T58","span":{"begin":1681,"end":1685},"obj":"Complex"},{"id":"T59","span":{"begin":1775,"end":1780},"obj":"Complex"},{"id":"T60","span":{"begin":1785,"end":1790},"obj":"Complex"}],"text":"IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathways.\nInterleukin (IL)-23 is an essential cytokine involved in the expansion of a novel CD4(+) T helper subset known as Th17, which has been implicated in the pathogenesis of periodontitis recently. This study hypothesised that Th17 signature cytokine IL-17 may target specialised human periodontal ligament fibroblasts (hPDLFs) for production of IL-23 p19, a key subunit of IL-23. Primary hPDLFs had steady expression of IL-17 receptor (IL-17R) mRNA and surface-bound protein. IL-17 was capable of stimulating the expression of IL-23 p19 mRNA and protein in cultured hPDLFs, which was attenuated by IL-17 or IL-17R neutralising antibodies. In accordance with the enhanced expression of IL-23 p19, IL-17 stimulation resulted in rapid activation of Akt, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK) 1/2, c-Jun-N-terminal kinase (JNK), nuclear factor-kappaB (NF-κB), and activator protein-1 (AP-1) in hPDLFs. Inhibitors of Akt, p38 MAPK, ERK 1/2, or NF-κB significantly suppressed, whereas blocking JNK and AP-1 substantially augmented IL-23 p19 production from IL-17-stimulated hPDLFs. Moreover, IL-17-initiated NF-κB activation was blocked by Akt, p38 MAPK, or ERK 1/2 inhibition, while AP-1 activity was specifically abrogated by JNK inhibition. Thus, these results provide evidence that hPDLFs are a target of Th17, and that IL-17 appears to up-regulate the expression of IL-23 p19 via a homeostatic mechanism involving Akt-, p38 MAPK-, and ERK 1/2-dependent NF-κB signalling versus the JNK/AP-1 pathway. Taken together, our findings suggest that disruption of the interaction between IL-17 and IL-23 may be a potential therapeutic approach in the treatment of periodontitis."}

{"project":"Allie","denotations":[{"id":"SS1_21145111_1_0","span":{"begin":150,"end":161},"obj":"expanded"},{"id":"SS2_21145111_1_0","span":{"begin":163,"end":165},"obj":"abbr"},{"id":"SS1_21145111_2_0","span":{"begin":425,"end":463},"obj":"expanded"},{"id":"SS2_21145111_2_0","span":{"begin":465,"end":471},"obj":"abbr"},{"id":"SS1_21145111_3_0","span":{"begin":566,"end":580},"obj":"expanded"},{"id":"SS2_21145111_3_0","span":{"begin":582,"end":588},"obj":"abbr"},{"id":"SS1_21145111_5_0","span":{"begin":901,"end":933},"obj":"expanded"},{"id":"SS2_21145111_5_0","span":{"begin":935,"end":939},"obj":"abbr"},{"id":"SS1_21145111_5_1","span":{"begin":942,"end":979},"obj":"expanded"},{"id":"SS2_21145111_5_1","span":{"begin":981,"end":984},"obj":"abbr"},{"id":"SS1_21145111_5_2","span":{"begin":991,"end":1014},"obj":"expanded"},{"id":"SS2_21145111_5_2","span":{"begin":1016,"end":1019},"obj":"abbr"},{"id":"SS1_21145111_5_3","span":{"begin":1022,"end":1043},"obj":"expanded"},{"id":"SS2_21145111_5_3","span":{"begin":1045,"end":1050},"obj":"abbr"},{"id":"SS1_21145111_5_4","span":{"begin":1057,"end":1076},"obj":"expanded"},{"id":"SS2_21145111_5_4","span":{"begin":1078,"end":1082},"obj":"abbr"}],"relations":[{"id":"AE1_21145111_1_0","pred":"abbreviatedTo","subj":"SS1_21145111_1_0","obj":"SS2_21145111_1_0"},{"id":"AE1_21145111_2_0","pred":"abbreviatedTo","subj":"SS1_21145111_2_0","obj":"SS2_21145111_2_0"},{"id":"AE1_21145111_3_0","pred":"abbreviatedTo","subj":"SS1_21145111_3_0","obj":"SS2_21145111_3_0"},{"id":"AE1_21145111_5_0","pred":"abbreviatedTo","subj":"SS1_21145111_5_0","obj":"SS2_21145111_5_0"},{"id":"AE1_21145111_5_1","pred":"abbreviatedTo","subj":"SS1_21145111_5_1","obj":"SS2_21145111_5_1"},{"id":"AE1_21145111_5_2","pred":"abbreviatedTo","subj":"SS1_21145111_5_2","obj":"SS2_21145111_5_2"},{"id":"AE1_21145111_5_3","pred":"abbreviatedTo","subj":"SS1_21145111_5_3","obj":"SS2_21145111_5_3"},{"id":"AE1_21145111_5_4","pred":"abbreviatedTo","subj":"SS1_21145111_5_4","obj":"SS2_21145111_5_4"}],"text":"IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathways.\nInterleukin (IL)-23 is an essential cytokine involved in the expansion of a novel CD4(+) T helper subset known as Th17, which has been implicated in the pathogenesis of periodontitis recently. This study hypothesised that Th17 signature cytokine IL-17 may target specialised human periodontal ligament fibroblasts (hPDLFs) for production of IL-23 p19, a key subunit of IL-23. Primary hPDLFs had steady expression of IL-17 receptor (IL-17R) mRNA and surface-bound protein. IL-17 was capable of stimulating the expression of IL-23 p19 mRNA and protein in cultured hPDLFs, which was attenuated by IL-17 or IL-17R neutralising antibodies. In accordance with the enhanced expression of IL-23 p19, IL-17 stimulation resulted in rapid activation of Akt, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK) 1/2, c-Jun-N-terminal kinase (JNK), nuclear factor-kappaB (NF-κB), and activator protein-1 (AP-1) in hPDLFs. Inhibitors of Akt, p38 MAPK, ERK 1/2, or NF-κB significantly suppressed, whereas blocking JNK and AP-1 substantially augmented IL-23 p19 production from IL-17-stimulated hPDLFs. Moreover, IL-17-initiated NF-κB activation was blocked by Akt, p38 MAPK, or ERK 1/2 inhibition, while AP-1 activity was specifically abrogated by JNK inhibition. Thus, these results provide evidence that hPDLFs are a target of Th17, and that IL-17 appears to up-regulate the expression of IL-23 p19 via a homeostatic mechanism involving Akt-, p38 MAPK-, and ERK 1/2-dependent NF-κB signalling versus the JNK/AP-1 pathway. Taken together, our findings suggest that disruption of the interaction between IL-17 and IL-23 may be a potential therapeutic approach in the treatment of periodontitis."}